Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/7/2025

Conservative Treatment of a 6mm Prevesical Stone

Introduction to Conservative Treatment

  • The European Association of Urology (EAU) recommends conservative treatment for ureteral stones up to 6mm in size, as stated in the EAU guidelines 1, 2
  • The American Urological Association (AUA) guidelines suggest a maximum duration of conservative treatment of 4-6 weeks from the initial clinical presentation to avoid irreversible kidney damage 1, 4

Principles of Conservative Treatment

  • Conservative treatment of uncomplicated ureteral stones is possible, with the EAU guidelines setting a threshold of 6mm for observation 1, 3
  • Regular follow-up is mandatory for conservative treatment 1, 2

Medical Therapy

  • Medical expulsive therapy (MET) with alpha-blockers is an option, particularly for distal ureteral stones larger than 5mm, as recommended by the European Urology guidelines 5, 6
  • Nonsteroidal anti-inflammatory drugs (NSAIDs; diclofenac, ibuprofen, metamizol) are the first-line treatment for renal colic 5, 6
  • Opioids are recommended as second-line analgesics when NSAIDs are contraindicated 6

Monitoring and Intervention

  • Regular imaging follow-up is necessary to monitor stone passage and detect complications early 1, 7
  • Intervention should be considered if the stone has not passed after 4-6 weeks, or if complications such as infections, sepsis, or anuria occur 1, 4, 5, 6
  • Intervention is also recommended in cases of severe, uncontrolled pain or obstruction with kidney swelling 6, 7
  • In cases of sepsis and/or anuria with obstructed kidney, urgent decompression of the system via percutaneous nephrostomy or ureteral stenting is strongly recommended 6

Special Considerations

  • Urine microscopy and culture results should be obtained before any stone treatment to exclude or treat urinary tract infections 6
  • Patients with bleeding disorders or those on antithrombotic therapy should be consulted with an internist for appropriate therapeutic measures 6